Dialysis fluid shows promise in slowing artery hardening
NCT ID NCT04956120
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether adding citrate to the fluid used during dialysis can slow the buildup of calcium in blood vessels. 54 adults on hemodialysis who already had some vessel hardening took part. Each person used a standard fluid for 12 months and a citrate fluid for another 12 months, and doctors measured changes in calcium buildup using mammograms. The goal was to see if citrate could help protect blood vessels over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory Dialysis at Candler
Decatur, Georgia, 30034, United States
-
Emory Dialysis at Greenbriar
Atlanta, Georgia, 30331, United States
-
Emory Dialysis at North Decatur
Decatur, Georgia, 30033, United States
-
Emory Dialysis at Northside
Atlanta, Georgia, 30318, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug work safely in patients with kidney failure?
- What does life feel like for children with a rare birth defect? a new study asks
- AI therapy coach aims to ease distress in seriously ill seniors
- A simple stretch during dialysis might soothe restless legs
- A regenerative graft could rethink dialysis access
- Pumpkin seed oil may fight inflammation in kidney patients — a trial puts it to the test